Zhengye Biotechnology Holding (ZYBT) Property, Plant & Equipment (Net) (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) Property, Plant & Equipment (Net) (2023 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Haleon	89.28 Bn	87.42 Bn	-	37.35 Bn
2	Teva Pharmaceutical Industries	35.97 Bn	32.23 Bn	1.97 Bn	4.00 Bn
3	Zoetis	32.42 Bn	30.48 Bn	1.62 Bn	3.72 Bn
4	Takeda Pharmaceutical	27.48 Bn	23.42 Bn	4.39 Bn	13.52 Bn
5	United Therapeutics	22.89 Bn	20.73 Bn	648.10 Mn	1.84 Bn
6	RedHill Biopharma	22.11 Bn	22.11 Bn	-	49,000.00
7	Viatris	20.44 Bn	18.64 Bn	1.16 Bn	2.53 Bn
8	Neurocrine Biosciences	17.76 Bn	16.44 Bn	800.70 Mn	90.90 Mn
9	Elanco Animal Health	12.62 Bn	12.19 Bn	785.00 Mn	1.40 Bn
10	Zhengye Biotechnology Holding	69.50 Mn	62.18 Mn	-	33.39 Mn

Download Data